{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T10:38:00Z","timestamp":1789382280222,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1038\/s41418-025-01559-8","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T22:16:23Z","timestamp":1755555383000},"page":"126-139","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["TRIM32 promotes anoikis resistance and metastasis in NSCLC by degrading CHEK2 to enhance IL-6 secretion"],"prefix":"10.1038","volume":"33","author":[{"given":"Jia","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongze","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4159-9758","authenticated-orcid":false,"given":"Xue","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangbo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,18]]},"reference":[{"key":"1559_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca Cancer J Clin. 2021;71:209\u201349.","journal-title":"Ca Cancer J Clin"},{"key":"1559_CR2","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S0140-6736(21)00312-3","volume":"398","author":"AA Thai","year":"2021","unstructured":"Thai AA, Solomon BJ, Sequist LV, Gainor JF, Heist RS. Lung cancer. Lancet. 2021;398:535\u201354.","journal-title":"Lancet"},{"key":"1559_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-6621-1","volume":"20","author":"C Wang","year":"2020","unstructured":"Wang C, Wu Y, Shao J, Liu D, Li W. Clinicopathological variables influencing overall survival, recurrence and post-recurrence survival in resected stage I non-small-cell lung cancer. BMC Cancer. 2020;20:150.","journal-title":"BMC Cancer"},{"key":"1559_CR4","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s41568-020-00300-6","volume":"20","author":"CA Klein","year":"2020","unstructured":"Klein CA. Cancer progression and the invisible phase of metastatic colonization. Nat Rev Cancer. 2020;20:681\u201394.","journal-title":"Nat Rev Cancer"},{"key":"1559_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111450","volume":"138","author":"S Xie","year":"2021","unstructured":"Xie S, Wu Z, Qi Y, Wu B, Zhu X. The metastasizing mechanisms of lung cancer: recent advances and therapeutic challenges. Biomed Pharmacother. 2021;138:111450.","journal-title":"Biomed Pharmacother"},{"key":"1559_CR6","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/path.3000","volume":"226","author":"ML Taddei","year":"2012","unstructured":"Taddei ML, Giannoni E, Fiaschi T, Chiarugi P. Anoikis: an emerging hallmark in health and diseases. J Pathol. 2012;226:380\u201393.","journal-title":"J Pathol"},{"key":"1559_CR7","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/S0955-0674(97)80124-X","volume":"9","author":"SM Frisch","year":"1997","unstructured":"Frisch SM, Ruoslahti E. Integrins and anoikis. Curr Opin Cell Biol. 1997;9:701\u20136.","journal-title":"Curr Opin Cell Biol"},{"key":"1559_CR8","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.canlet.2008.05.029","volume":"272","author":"CD Simpson","year":"2008","unstructured":"Simpson CD, Anyiwe K, Schimmer AD. Anoikis resistance and tumor metastasis. Cancer Lett. 2008;272:177\u201385.","journal-title":"Cancer Lett"},{"key":"1559_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118985","volume":"268","author":"W Zhan","year":"2021","unstructured":"Zhan W, Zhang S. TRIM proteins in lung cancer: mechanisms, biomarkers and therapeutic targets. Life Sci. 2021;268:118985.","journal-title":"Life Sci"},{"key":"1559_CR10","doi-asserted-by":"crossref","unstructured":"Bawa S, Piccirillo R, Geisbrecht ER. TRIM32: a multifunctional protein involved in muscle homeostasis, glucose metabolism, and tumorigenesis. Biomolecules. 2021;11:408.","DOI":"10.3390\/biom11030408"},{"key":"1559_CR11","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.biocel.2016.07.023","volume":"79","author":"E Lazzari","year":"2016","unstructured":"Lazzari E, Meroni G. TRIM32 ubiquitin E3 ligase, one enzyme for several pathologies: from muscular dystrophy to tumours. Int J Biochem Cell B. 2016;79:469\u201377.","journal-title":"Int J Biochem Cell B"},{"key":"1559_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06026-1","volume":"14","author":"A Romagnoli","year":"2023","unstructured":"Romagnoli A, Di Rienzo M, Petruccioli E, Fusco C, Palucci I, Micale L, et al. The ubiquitin ligase TRIM32 promotes the autophagic response to Mycobacterium tuberculosis infection in macrophages. Cell Death Dis. 2023;14:505.","journal-title":"Cell Death Dis"},{"key":"1559_CR13","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1007\/s10753-021-01597-7","volume":"45","author":"Z Chen","year":"2022","unstructured":"Chen Z, Tian L, Wang L, Ma X, Lei F, Chen X, et al. TRIM32 inhibition attenuates apoptosis, oxidative stress, and inflammatory injury in podocytes induced by high glucose by modulating the Akt\/GSK-3beta\/Nrf2 pathway. Inflammation. 2022;45:992\u20131006.","journal-title":"Inflammation"},{"key":"1559_CR14","doi-asserted-by":"publisher","first-page":"u8857","DOI":"10.1126\/sciadv.aau8857","volume":"5","author":"M Di Rienzo","year":"2019","unstructured":"Di Rienzo M, Antonioli M, Fusco C, Liu Y, Mari M, Orhon I, et al. Autophagy induction in atrophic muscle cells requires ULK1 activation by TRIM32 through unanchored K63-linked polyubiquitin chains. Sci Adv. 2019;5:u8857.","journal-title":"Sci Adv"},{"key":"1559_CR15","doi-asserted-by":"publisher","first-page":"5020","DOI":"10.1111\/jcmm.13784","volume":"22","author":"C Wang","year":"2018","unstructured":"Wang C, Xu J, Fu H, Zhang Y, Zhang X, Yang D, et al. TRIM32 promotes cell proliferation and invasion by activating beta-catenin signalling in gastric cancer. J Cell Mol Med. 2018;22:5020\u20138.","journal-title":"J Cell Mol Med"},{"key":"1559_CR16","doi-asserted-by":"publisher","first-page":"5572","DOI":"10.1158\/0008-5472.CAN-07-6231","volume":"68","author":"S Kano","year":"2008","unstructured":"Kano S, Miyajima N, Fukuda S, Hatakeyama S. Tripartite motif protein 32 facilitates cell growth and migration via degradation of Abl-interactor 2. Cancer Res. 2008;68:5572\u201380.","journal-title":"Cancer Res"},{"key":"1559_CR17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.4161\/cam.4.1.9834","volume":"4","author":"C Huang","year":"2010","unstructured":"Huang C. Roles of E3 ubiquitin ligases in cell adhesion and migration. Cell Adhes Migr. 2010;4:10\u20138.","journal-title":"Cell Adhes Migr"},{"key":"1559_CR18","doi-asserted-by":"publisher","first-page":"C695","DOI":"10.1152\/ajpcell.00386.2019","volume":"318","author":"F Chen","year":"2020","unstructured":"Chen F, Guo Q, Chen Q, Han Z, Zhou X, Wu L, et al. TRIM32 triggers beta-catenin signaling through ubiquitylation of AXIN1 to promote inflammatory factor-induced apoptosis of rat nucleus pulposus cells. AM J Physiol Cell PH. 2020;318:C695\u2013703.","journal-title":"AM J Physiol Cell PH"},{"key":"1559_CR19","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s41571-021-00588-9","volume":"19","author":"DJ Propper","year":"2022","unstructured":"Propper DJ, Balkwill FR. Harnessing cytokines and chemokines for cancer therapy. Nat Rev Clin Oncol. 2022;19:237\u201353.","journal-title":"Nat Rev Clin Oncol"},{"key":"1559_CR20","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41416-018-0328-y","volume":"120","author":"P Berraondo","year":"2019","unstructured":"Berraondo P, Sanmamed MF, Ochoa MC, Etxeberria I, Aznar MA, Perez-Gracia JL, et al. Cytokines in clinical cancer immunotherapy. Brit J Cancer. 2019;120:6\u201315.","journal-title":"Brit J Cancer"},{"key":"1559_CR21","doi-asserted-by":"publisher","first-page":"11553","DOI":"10.1007\/s13277-016-5098-7","volume":"37","author":"N Kumari","year":"2016","unstructured":"Kumari N, Dwarakanath BS, Das A, Bhatt AN. Role of interleukin-6 in cancer progression and therapeutic resistance. Tumour Biol. 2016;37:11553\u201372.","journal-title":"Tumour Biol"},{"key":"1559_CR22","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.trecan.2022.04.009","volume":"8","author":"R Boonen","year":"2022","unstructured":"Boonen R, Vreeswijk M, van Attikum H. CHEK2 variants: linking functional impact to cancer risk. Trends Cancer. 2022;8:759\u201370.","journal-title":"Trends Cancer"},{"key":"1559_CR23","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1007\/s12253-019-00745-7","volume":"26","author":"PJ Spachmann","year":"2020","unstructured":"Spachmann PJ, Azzolina V, Weber F, Evert M, Eckstein M, Denzinger S, et al. Loss of CHEK2 predicts progression in stage pT1 non-muscle-invasive bladder cancer (NMIBC). Pathol Oncol Res. 2020;26:1625\u201332.","journal-title":"Pathol Oncol Res"},{"key":"1559_CR24","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1002\/ijc.25003","volume":"126","author":"J Suchy","year":"2010","unstructured":"Suchy J, Cybulski C, Wokolorczyk D, Oszurek O, Gorski B, Debniak T, et al. CHEK2 mutations and HNPCC-related colorectal cancer. Int J Cancer. 2010;126:3005\u20139.","journal-title":"Int J Cancer"},{"key":"1559_CR25","doi-asserted-by":"crossref","unstructured":"Stolarova L, Kleiblova P, Janatova M, Soukupova J, Zemankova P, Macurek L, et al. CHEK2 germline variants in cancer predisposition: stalemate rather than checkmate. Cells. 2020;9:2675.","DOI":"10.3390\/cells9122675"},{"key":"1559_CR26","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.7150\/thno.95485","volume":"14","author":"HF Hu","year":"2024","unstructured":"Hu HF, Han L, Fu JY, He X, Tan JF, Chen QP, et al. LINC00982-encoded protein PRDM16-DT regulates CHEK2 splicing to suppress colorectal cancer metastasis and chemoresistance. Theranostics. 2024;14:3317\u201338.","journal-title":"Theranostics"},{"key":"1559_CR27","volume":"6","author":"T Tanaka","year":"2014","unstructured":"Tanaka T, Narazaki M, Kishimoto T. IL-6 in inflammation, immunity, and disease. Csh Perspect Biol. 2014;6:a16295.","journal-title":"Csh Perspect Biol"},{"key":"1559_CR28","doi-asserted-by":"crossref","unstructured":"Tanaka T, Narazaki M, Kishimoto T. Interleukin (IL-6) Immunotherapy. Csh Perspect Biol. 2018;10:a028456.","DOI":"10.1101\/cshperspect.a028456"},{"key":"1559_CR29","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/ni.3153","volume":"16","author":"CA Hunter","year":"2015","unstructured":"Hunter CA, Jones SA. IL-6 as a keystone cytokine in health and disease. Nat Immunol. 2015;16:448\u201357.","journal-title":"Nat Immunol"},{"key":"1559_CR30","doi-asserted-by":"publisher","first-page":"76116","DOI":"10.18632\/oncotarget.18814","volume":"8","author":"L Wang","year":"2017","unstructured":"Wang L, Cao L, Wang H, Liu B, Zhang Q, Meng Z, et al. Cancer-associated fibroblasts enhance metastatic potential of lung cancer cells through IL-6\/STAT3 signaling pathway. Oncotarget. 2017;8:76116\u201328.","journal-title":"Oncotarget"},{"key":"1559_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2614-5","volume":"16","author":"MA Al-Rakan","year":"2016","unstructured":"Al-Rakan MA, Hendrayani SF, Aboussekhra A. CHEK2 represses breast stromal fibroblasts and their paracrine tumor-promoting effects through suppressing SDF-1 and IL-6. BMC Cancer. 2016;16:575.","journal-title":"BMC Cancer"}],"container-title":["Cell Death &amp; Differentiation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41418-025-01559-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-025-01559-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-025-01559-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T14:03:27Z","timestamp":1768572207000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41418-025-01559-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,18]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["1559"],"URL":"https:\/\/doi.org\/10.1038\/s41418-025-01559-8","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,18]]},"assertion":[{"value":"27 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal experiments were conducted according to the guidelines of the First Affiliated Hospital of Soochow University and approved by the Laboratory Animal Ethics Committee of Soochow University. The present study was approved by the Bioscience Ethics Review Committee of Hunan Aifang Biotechnology Co., Ltd., and all enrolled patients provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}